UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
_________________
Date of Report (Date of earliest event reported): September 16, 2013
InspireMD, Inc.
(Exact name of registrant as specified in its charter)
Delaware | | 001-35731 | | 26-2123838 |
(State or other jurisdiction
of incorporation) | | (Commission File Number) | | (IRS Employer
Identification No.) |
| | | |
800 Boylston Street, Suite 16041 Boston, Massachusetts | | 02199 |
| (Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (857) 453-6553
| (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition.
On September 17, 2013, InspireMD, Inc. (the “Company”) issued a press release announcing its financial results for its fourth quarter and fiscal year ended June 30, 2013. A copy of this press release is attached hereto as Exhibit 99.1.
In accordance with General Instruction B.2 of Form 8-K, the information in this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On September 16, 2013, the Company’s board of directors approved a change in the Company’s fiscal year-end from June 30 to December 31. The Company plans to report its financial results for the six month transition period of July 1, 2013 through December 31, 2013 on an Annual Report on Form 10-K/T and to thereafter file reports for each twelve month period ended December 31 of each year beginning with the twelve month period ended December 31, 2014.
Item 9.01 Financial Statements and Exhibits.
| Exhibit Number | | Description |
| 99.1 | | Earnings release dated September 17, 2013 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | InspireMD, Inc. |
| | |
| | |
| Date: September 18, 2013 | By: /s/ Craig Shore |
| | Name: Craig Shore |
| | Title: Chief Financial Officer |
EXHIBIT INDEX
| Exhibit Number | | Description |
| 99.1 | | Earnings release dated September 17, 2013 |
